BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 19, 2021
View Archived Issues
Carrimycin studied in phase III to treat severe COVID-19 in hospitalized patients
Read More
GlaxoSmithKline begins phase I/II study of influenza vaccine candidate GSK-3206641A
Read More
Phase III study of chiauranib in SCLC begins
Read More
First patients treated in phase I/II trial of pyrilutamide for acne in China
Read More
NMPA of China approved IND application for HLX-26
Read More
BOLD-100 shows robust preclinical efficacy against COVID-19 variants
Read More
New PROTAC induces degradation of hematopoietic prostaglandin D synthase
Read More
Optimization of indolinylpyrimidine derivatives to obtain potent orally bioavailable GPR119 agonists
Read More
Transcenta begins phase I evaluation of TST-001 with CAPOX for gastric cancer
Read More
Phase I study of eryaspase in first-line pancreatic cancer escalates to next cohort
Read More
Beijing Jacobio Pharmaceuticals divulges new KRAS inhibitors
Read More
FDA approves Nextstellis for prevention of pregnancy
Read More
Nanjing TransThera Biosciences patents PADI4 inhibitors
Read More
Medshine Discovery presents new BTK inhibitors
Read More
Shenzhen Targetrx Biotechnology synthesizes Ret inhibitors
Read More
New MISRI-targeting antibodies presented by French researchers
Read More
U.S. approval for Opdivo with chemotherapy for advanced gastric cancers
Read More
Autotaxin inhibitor BIO-32546 for neuropathic pain
Read More
Loxo Oncology presents next-generation RET inhibitor candidates
Read More
Discovery of EU-129 for treatment of severe COVID-19 in patients with underlying diseases
Read More
SYD-1875 shows promising antitumor activity in PDX models of multiple tumor types
Read More
European Commission approves Sarclisa with Kd for relapsed multiple myeloma
Read More
BerGenBio updates progress from phase II studies of bemcentinib in COVID-19
Read More
FDA clears IND for phase IIa study of naptumomab estafenatox in NSCLC
Read More
Biond opens phase I/II trial of BND-22 in advanced solid tumors
Read More
Brain injury modulates bone marrow cells to reduce neuroinflammation
Read More